Compound Profiles
BPC-157
Body Protection Compound-157 | Pentadecapeptide
Promotes blood vessel formation (angiogenesis), enhances collagen synthesis, modulates growth factor expression including VEGF, and protects against tissue damage through localized or systemic delivery pathways..
Telmisartan
Angiotensin II Receptor Blocker | Cardiac Protection On Cycle
Telmisartan selectively blocks the angiotensin II type 1 (AT1) receptor, preventing angiotensin II from exerting its vasoconstrictive, aldosterone-secreting, and pro-fibrotic effects. By antagonizing AT1, telmisartan lowers systemic vascular resistance and blood pressure while simultaneously reducing pathological cardiac and vascular remodeling.
Combined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take BPC-157 with Telmisartan?
Yes, BPC-157 and Telmisartan can generally be taken together. BPC-157 reduces inflammation while Telmisartan promotes tissue repair. Reducing inflammation creates a more favorable environment for healing.
Is BPC-157 and Telmisartan safe together?
Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: teratogenic. Monitor accordingly.
What are the interactions between BPC-157 and Telmisartan?
BPC-157 reduces inflammation while Telmisartan promotes tissue repair. Reducing inflammation creates a more favorable environment for healing. This assessment has 50% confidence and is inferred from pharmacological mechanism analysis.
How should I time BPC-157 and Telmisartan?
BPC-157 has a half-life of <30 minutes and Telmisartan has a half-life of ~24 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.